Á¦4ȸ ´ëÇѼÒȱâÇÐȸ °æ±âÀÎõÁöȸ ½ÉÆ÷Áö¾ö ¹× ¿¬±¸°úÁ¦ ¹ßǥȸ : 2024-07-20
±³À°ÀÏÀÚ : 2024-07-20
±³À°Àå¼Ò : °¡Å縯´ëÇб³ ¼ºÀDZ³Á¤ ¸¶¸®¾ÆȦ
±³À°ÁÖÁ¦ : Á¦4ȸ ´ëÇѼÒȱâÇÐȸ °æ±âÀÎõÁöȸ ½ÉÆ÷Áö¾ö ¹× ¿¬±¸°úÁ¦ ¹ßǥȸ
ÁÖÃÖ±â°ü : ´ëÇѼÒȱâÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѼÒȱâÇÐȸ °æ±â.ÀÎõÁöȸ
´ã´çÀÚ : À±Ã¤Çõ
¿¬¶ôó : 02-0000-0000
À̸ÞÀÏ : cmyk25@gmail.com
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 10,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 12:50~12:55 °³È¸»ç ±èº´¿í(´ëÇѼÒȱâÇÐȸ °æ±â‧ÀÎõÁöȸ ȸÀå)
±âŸ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 12:55~13:00 Ãà»ç ±èÁÖ¼º(´ëÇѼÒȱâÇÐȸ ÀÌ»çÀå)
±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 13:00~13:20 ÀÇ·á µ¿¿µ»óÀ» ÀÌ¿ëÇÑ ÀΰøÁö´É ¿¬±¸ »ç·Ê ±è±¤±â(°¡Ãµ´ë ±æº´¿ø ÀÇ°øÇаú)
±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 13:20~13:40 »ý¼ºÇü ÀΰøÁö´ÉÀÇ ÇöȲ°ú ÀÇ·á ºÐ¾ß Àû¿ë »ç·Ê Á¤±Ôȯ(¼º±Õ°ü´ë »ï¼ºÀ¶ÇÕÀÇ°úÇпø)
±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 13:40~14:00 Ãé´ãµµ ¿µ¿ª¿¡¼ ÀÇ·á Àΰø Áö´ÉÀÇ ÀÀ¿ë ÃÖ¼ºÁö(ÇѾç´ëº´¿ø)
±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 14:00~14:20 ¿°Áõ¼º ÀåÁúȯ¿¡¼ ÀΰøÁö´É ¿¬±¸ÀÇ ÃֽŠÁö°ß ±èÀ±Àç(ÀåÁÁÀº³»°ú)
±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 14:20~14:35 ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ±â¹Ý ÃéÀå¾Ï Áø´Ü ¹× ¿¹ÈÄ ¿¹Ãø ¹ÙÀÌ¿À¸¶Ä¿ °³¹ß¿¡ °üÇÑ ¿¬±¸ ÀÌÁ¤³²(ÀÎÇϴ뺴¿ø)
±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 14:35~14:50 Anti-inflammatory properties of hemostatic powder (UI-EWD) after endoscopic submucosal dissection (ESD) for nonpedunculated colorectal tumors ÀÌ¿ø¸í(¼øõÇâ´ë ºÎõº´¿ø)
±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 14:50~15:05 Ç÷û Æé½Ã³ë°Õ I/II¿¡ µû¸¥ À§Á¡¸· ¸¶ÀÌÅ©·Î¹ÙÀÌ¿ÈÀÇ ±¸¼º ±èº´¿í(°¡Å縯´ë ÀÎõ¼º¸ðº´¿ø)
±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 15:05~15:20 Comparison between transpapillary and suprapapillary metal stent placement with endoscopic sphincterotomy in common bile duct malignant obstruction: prospective randomized controlled study ÀåÀçÇõ(°¡Å縯´ë ºÎõ¼º¸ðº´¿ø)
ÈÞ½Ä 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 15:20~15:30 Break ()
±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 15:30~15:45 Significance of 8-OHdG Expression as a Predictor of Survival in Colorectal Cancer ±èÁ¤È£(°¡Ãµ´ë ±æº´¿ø)
±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 15:45~16:00 Incidence and risk of pancreatic cancer in patients with chronic pancreatitis: Defining the optimal subgroup for surveillance ÀåÀçÇõ(°¡Å縯´ë ºÎõ¼º¸ðº´¿ø)
±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 16:00~16:15 Efficacy of tegoprazan-based bismuth quadruple therapy compared with bismuth quadruple therapy for Helicobacter pylori infection: A randomized, double-blind, active-controlled study ±èÁؼº(°¡Å縯´ë ÀÎõ¼º¸ðº´¿ø)
±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 16:15~16:30 ´Ù±â°ü ±Þ¼º ÃéÀå¿° ÄÚȣƮ¸¦ ÀÌ¿ëÇÑ ±Þ¼º ÃéÀå¿°ÀÇ ÅëÁõ Èıâ ÇÕº´Áõ (»ç¸Á ¶Ç´Â ½Ã¼ú ½ÃÇà) ¹ß»ýÀÇ Á¶±â ¿¹Ãø¿¡ °üÇÑ ¿¬±¸ °ÈÆò(°¡Ãµ´ë±æº´¿ø)
±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 16:30~16:45 º´¿ø°øÀ¯µ¥ÀÌÅ͸¦ ÀÌ¿ëÇÑ ¿ì¿¬È÷ ¹ß°ßµÈ ÀÛÀº ÃéÀ島Á¾ÀÇ ÀÚ¿¬»ç¿Í ¾Ç¼º ¿¹Ãø¿¡ °üÇÑ ¿¬±¸ ±èÈ¿¼®(°¡Å縯´ë ºÎõ¼º¸ðº´¿ø)
±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 16:45~17:00 ´ã°ü °á¼®À» Á¦°ÅÇÑ È¯ÀÚ¿¡¼ ´ã°ü³» Á¾¾ç¼º º´º¯ÀÇ ¼±º°Áø´ÜÀ» À§ÇÑ ÀÏȸ¿ë ´ÜÀÏ-½Ã¼úÀÚ ´ãµµ³»½Ã°æÀÇ À¯¿ë¼º¿¡ °üÇÑ ¿¬±¸ ½ÅÀÏ»ó(¼øõÇâ´ë ºÎõº´¿ø)
±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 17:00~17:15 µÅÁö¸ðµ¨¿¡¼ balloon-equipped light diffuser¸¦ ÀÌ¿ëÇÑ ÇϺΠ½Äµµ °ý¾à±ÙÀÇ ³»½Ã°æ ·¹ÀÌÀú Ä¡·á È¿°ú¿¡ °üÇÑ ¿¬±¸ Â÷º¸¶÷(ÀÎÇϴ뺴¿ø)
Åä·Ð 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 17:15~17:30 Discussion ()
±âŸ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 17:30~17:50 ´ëÇѼÒȱâÇÐȸ °æ±â‧ÀÎõÁöȸ Çмú»ó ¹× ¿¬±¸Çмú»ó ¼ö»óÀÚ ¹ßÇ¥ ±èÅÂÈ£(´ëÇѼÒȱâÇÐȸ °æ±â‧ÀÎõÁöȸ Ãѹ«ÀÌ»ç)
±âŸ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 17:50~18:00 Æóȸ»ç Á¤¼®(´ëÇѼÒȱâÇÐȸ °æ±â‧ÀÎõÁöȸ ºÎȸÀå)